or Try an Advanced Search...

    Technical Analysis for NRBO - NeuroBo Pharmaceuticals, Inc.

    Grade Last Price % Change Price Change
    F 4.24 3.16% 0.13
    NRBO closed up 3.16 percent on Wednesday, May 15, 2024, on 33 percent of normal volume. Due to the stock's strong uptrend, it may remain overbought for a while. So, if you're looking for a reason to sell, don't put too much weight on it being overbought.
    0 Watchers
    Watchlist Portfolio

    Trend Table & Recent EOD Trading Signals

    ADX Long Term Intermediate Term Short Term
    Strong Up Up Up
    Historical NRBO trend table...
    Date Alert Name Type % Chg
    New Uptrend Bullish 0.00%
    Wide Bands Range Expansion 0.00%
    Overbought Stochastic Strength 0.00%
    Up 3 Days in a Row Strength 0.00%
    200 DMA Support Bullish 3.16%
    Crossed Above 50 DMA Bullish 3.16%
    Wide Bands Range Expansion 3.16%
    Overbought Stochastic Strength 3.16%
    50 DMA Resistance Bearish 5.21%
    Crossed Above 200 DMA Bullish 5.21%
    Older End-of-Day Signals for NRBO ...

       Recent Intraday Alerts

    Alert Time
    Rose Above Previous Day's High about 13 hours ago
    200 DMA Support 1 day ago
    Down 1% 1 day ago
    Rose Above Previous Day's High 3 days ago
    Rose Above 200 DMA 3 days ago
    View Earlier Intraday Alerts

    Free Daily (Stock) Chart Reading

    Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
    Get Started for Free!
    Configure default chart indicators
    NRBO Chart by TradingView
    Basic chart:

    Profile

    Researches and develops disease-modifying therapies for neurodegenerative diseases
    Classification
    Sector: Healthcare
    Industry: Biotechnology
    Keywords: Biology Organ Systems Neuroscience Stem Cell Neurodegenerative Diseases Degenerative Disease Neurodegeneration Senescence

    Is NRBO a Buy, Sell or Hold?

    Indicator Bull Case Neutral / Hold Bear Case
    50 DMA
    200 DMA
    ADX Trend
    Oversold / Overbought
    Relative Strength
    Counts: 3 bullish, 1 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.

    Recent News

    Date Title
    May 9 NeuroBo Pharmaceuticals GAAP EPS of -$1.32
    May 9 NeuroBo Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Corporate Update
    Apr 30 NeuroBo to Present Latest Pre-Clinical Data on Cardiometabolic Assets, DA-1241 and DA-1726, Targeting MASH and Obesity, at Scientific Conferences in June
    Apr 23 NRBO: First Patient Dosed in Phase 1 Trial of DA-1726 for the Treatment of Obesity…
    Apr 12 NeuroBo Pharmaceuticals files for $150M mixed shelf
    Apr 1 NeuroBo Pharmaceuticals Completes Enrollment of Part 1 of Its Phase 2a Clinical Trial Evaluating DA-1241 for the Treatment of MASH
    Mar 28 NeuroBo Pharmaceuticals GAAP EPS of -$2.46
    Mar 28 NeuroBo Pharmaceuticals Reports Year End 2023 Financial Results and Provides Corporate Update
    Mar 13 NeuroBo Phase 2a study for MASH drug to proceed as planned
    Mar 13 NeuroBo Pharmaceuticals Receives Safety Review Committee Approval to Continue With Its Phase 2a Clinical Trial Evaluating DA-1241 for the Treatment of MASH
    See more NRBO news...

    Comments

    View full discussion...

    Indicators

    Indicator Value
    52 Week High 6.7499
    52 Week Low 2.8888
    Average Volume 40,487
    200-Day Moving Average 3.98
    50-Day Moving Average 3.98
    20-Day Moving Average 3.59
    10-Day Moving Average 3.94
    Average True Range 0.23
    RSI (14) 66.78
    ADX 26.2
    +DI 30.55
    -DI 12.30
    Chandelier Exit (Long, 3 ATRs) 3.54
    Chandelier Exit (Short, 3 ATRs) 3.69
    Upper Bollinger Bands 4.37
    Lower Bollinger Band 2.81
    Percent B (%b) 0.91
    BandWidth 43.56
    MACD Line 0.08
    MACD Signal Line -0.03
    MACD Histogram 0.1137
    Fundamentals Value
    Market Cap 20.57 Million
    Num Shares 4.85 Million
    EPS -43.82
    Price-to-Earnings (P/E) Ratio -0.10
    Price-to-Sales 0.00
    Price-to-Book 1.03
    Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
    Resistance 4 (R4) 4.48
    Resistance 3 (R3) 4.45 4.35 4.44
    Resistance 2 (R2) 4.35 4.29 4.36 4.43
    Resistance 1 (R1) 4.29 4.25 4.32 4.32 4.41
    Pivot Point 4.19 4.19 4.20 4.20 4.19
    Support 1 (S1) 4.13 4.12 4.16 4.16 4.07
    Support 2 (S2) 4.03 4.09 4.04 4.05
    Support 3 (S3) 3.97 4.03 4.04
    Support 4 (S4) 4.00